At WinQure Medicine, we transform genetic diagnoses into therapeutic opportunities. We build the future model for development of ASO therapies for patients with ultra-rare genetic diseases who have no treatment options.

Our mission is simple: no patient should be too rare to matter.

Achieving this requires more than scientific excellence. It requires individuals who are ambitious, entrepreneurial, collaborative, and driven by the opportunity to make a meaningful difference for patients.

We work at the intersection of molecular medicine, drug development, and regulatory innovation, partnering closely with clinicians, researchers, regulators, manufacturers, and ultra-rare disease communities around the world.

As we grow, we will continue to expand our team across scientific, clinical, regulatory, operational, and commercial functions.